Tang Lab

Laboratory of Biomaterials for Immunoengineering

Unexpected immune response may hold key to long-term cancer remission

See more

Results from a preclinical study in mice, led by EPFL, and a collaborative clinical study in patients show that the type 2 immune response – associated with parasitic infection and thought to play a negative role in cancer immunity – is positively correlated with long-term cancer remission.

Our research

Our immune system is constantly defending us from many diseases through profound interactions with invaders or diseased cells. Such interactions are multi-dimensional, meaning that extensive biological, chemical, and physical exchanges are involved. With that in mind, the team of Tang Laboratory is developing novel strategies to engineer such multi-dimensional immunity-disease interactions from various aspects, an emerging field called ‘immunoengineering’, in order to create safe and effective therapies against cancer and infectious diseases.

Contact

Head of Laboratory : Li Tang
EPFL-STI-IBI/IMX-LBI
MED 1 2826, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0937
Email: [email protected]


Administrative Assistant : Monica Navarro Suarez
EPFL-STI-IBI/IMX-LBI
MED 1 2726, Station 9
CH-1015 Lausanne, Switzerland
Phone : +41 21 693 0756
Email: [email protected]


Access map